Not available
Quote | Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE)
Last: | $46.59 |
---|---|
Change Percent: | -1.2% |
Open: | $47.94 |
Close: | $46.59 |
High: | $47.94 |
Low: | $46.53 |
Volume: | 739,242 |
Last Trade Date Time: | 03/18/2024 03:00:00 am |
News | Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE)
2024-03-18 11:30:02 ET Wedbush analyst issues BUY recommendation for RARE on March 18, 2024 09:00AM ET. The previous analyst recommendation was Buy. RARE was trading at $47.78 at issue of the analyst recommendation. The overall analyst consensus : BUY. Current analys...
2024-03-11 11:53:40 ET Summary Positive interim results released from phase 1/2 AFFINITY study, using RGX-202 for the treatment of patients with Duchenne Muscular Dystrophy. Functional and strength data from the phase 1/2 AFFINITY study, using RGX-202 for the treatment of patients...
Message Board Posts | Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE)
Subject | By | Source | When |
---|---|---|---|
News; $RARE Ultragenyx Pharmaceutical Inc ($RARE) Q3 2020 | whytestocks | investorshub | 10/28/2020 11:15:29 AM |
Lets go !!! | Erz | investorshub | 06/02/2020 7:04:41 PM |
News: $RARE Ultragenyx Announces Sale of Future European | whytestocks | investorshub | 12/19/2019 2:00:42 AM |
News: $RARE Ultragenyx Expands Leadership Team and Promotes | whytestocks | investorshub | 06/17/2019 8:50:42 PM |
What does this Miss Primary end points mean | Scalp2Trade | investorshub | 10/26/2018 1:07:26 PM |
News, Short Squeeze, Breakout and More Instantly...
Ultragenyx Pharmaceutical Inc. Company Name:
RARE Stock Symbol:
NASDAQ Market:
Ultragenyx Pharmaceutical Inc. Website:
2024-03-18 11:30:02 ET Wedbush analyst issues BUY recommendation for RARE on March 18, 2024 09:00AM ET. The previous analyst recommendation was Buy. RARE was trading at $47.78 at issue of the analyst recommendation. The overall analyst consensus : BUY. Current analys...
44th Annual Cowen Healthcare Conference on March 4 Leerink Partners Global Biopharma Conference on March 12 Barclays 26th Annual Global Healthcare...
44 th Annual Cowen Healthcare Conference on March 4 Leerink Partners Global Biopharma Conference on March 12 Barclays 26 th Annual Global Healthcare Conference on March 13 NOVATO, Calif., Feb. 27, 2024 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceut...